Stanford University


Showing 651-660 of 870 Results

  • Sushma Reddy

    Sushma Reddy

    Associate Professor of Pediatrics (Cardiology)

    Current Research and Scholarly InterestsMy laboratory's expertise in cardiovascular phenotyping has led to the development of mouse models of congenital heart disease that recapitulate abnormal loading conditions on the heart. We have used these models to advance our understanding of the mechanisms of right heart failure in children and adults with congenital heart disease with the long term goal of identifying noninvasive diagnostic tools to better assess right ventricular health and to develop right ventricle specific therapeutics.

  • David Rehkopf

    David Rehkopf

    Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy

    BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.

    I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.

    My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.

    Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Chloe Reuter

    Chloe Reuter

    Clinical Associate Professor, Medicine - Cardiovascular Medicine
    Clinical Associate Professor, Pediatrics - Medical Genetics

    BioChloe Reuter is a Genetic Counselor and Clinical Associate Professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. She is Principal Investigator of an NIH-funded research program focused on developing frameworks for the clinical translation of multi-omic technologies in rare diseases.

    Ms. Reuter provides genetic counseling care at the Stanford Center for Inherited Cardiovascular Diseases, specializing in inherited cardiovascular conditions including cardiomyopathies, arrhythmia syndromes, and sudden cardiac death. She has expertise in interpreting complex genomic results from multi-gene panels, exome sequencing, and whole genome sequencing for patients with rare and undiagnosed diseases.

    Ms. Reuter's research centers on translating cutting-edge genomic technologies into clinical practice. She develops frameworks for integrating multi-omic data (genomic, transcriptomic, and other omics) into diagnostic workflows and contributes to evidence-based guidelines for variant interpretation and clinical curation. Her work addresses the ethical and practical challenges of implementing these technologies, with particular focus on patient engagement, equitable access to precision medicine, and protocols for returning complex research results. She also conducts genetic counseling practice research, examining patient experiences, psychosocial assessment tools, and healthcare delivery models including telehealth services.

    She has contributed to multiple national genomics initiatives including the Undiagnosed Diseases Network and the GREGoR Consortium, applying comprehensive genomic approaches to solve medical mysteries and improve diagnostic outcomes for patients with rare diseases.

  • William Rhine

    William Rhine

    Emeritus Faculty-Med Ctr Line, Pediatrics - Neonatology

    Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.

  • Tawna L. Roberts, OD, PhD

    Tawna L. Roberts, OD, PhD

    Associate Professor of Ophthalmology (Pediatric) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsOur research efforts are funded by grants from the National Eye Institute, Department of Defense, and various foundations to study vision development in infants and young children as well as binocular vision disorders in adolescents and adults with concussions. Our focus is to identify underlying mechanisms that will inform clinical treatment approaches and ultimately leading to the prevention of strabismus, amblyopia, and binocular vision disorders.